14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Idiopathic Parkinson Disease in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pallàs, M | 1 |
| Vázquez, S | 1 |
| Sanfeliu, C | 1 |
| Galdeano, C | 1 |
| Griñán-Ferré, C | 1 |
1 review available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Anti-Inflammatory Agents; Brain; Enzyme Inhibitors; Epoxide Hy | 2020 |